top of page
Insights That Move the GPCR Field Forward
Read the latest analyses, interviews, and discoveries shaping the GPCR ecosystem — from research breakthroughs to biotech strategy.
Blog: Blog2
Search
Yamina's Corner
Yamina’s Corner blends scientific depth with strategic clarity—offering insights for biotechs, CROs, and investors navigating GPCRs, pharmacology, and emerging biotech innovation. Grounded in experience and driven by curiosity, it’s where strategy meets science to inspire smarter decisions.


The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
A GPCR program can have brilliant science and talented people and still get stuck. The issue isn't a lack of effort; it's a lack of precision. The granular, often overlooked details are where programs falter, leading to unforeseen costs and delays. So, why do promising programs stall despite significant investment and a skilled team?

Yamina's Corner
Aug 203 min read


Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
This fundamental disconnect between the lab and the boardroom is precisely where programs get stuck—not because of bad science, but because companies find themselves throwing more money and people at problems that could be solved with better systems. This reactive approach, driven by a "go fast" mindset, burns through precious capital and time, leaving both scientific teams and investors frustrated.

Yamina's Corner
Aug 54 min read


From GPCR Data Chaos to Decisive Action
Is Your GPCR Program Slowing Down—Even With Good Data? You’re not alone. Most teams don’t stall because the science is weak. They stall...

Yamina's Corner
Jul 83 min read


Accelerating GPCR Drug Discovery
Why I Started GPCR Consulting You've got great data. You've got brilliant scientists. But your GPCR program still isn't moving at the...

Yamina's Corner
Jun 302 min read
bottom of page

